Number of Shares
962,883.00
Current Holdings Value*
$33.29 Mil
% of Portfolio
8.1%
Total Estimate Gain
$16.48 Mil
% of Total Estimate Gain
64.86%

Catalio Capital Management, LP's BridgeBio Pharma Inc Holding Summary

As of 2025-03-31, Catalio Capital Management, LP held 962,883.00 shares of BridgeBio Pharma Inc(BBIO), totaling $33.29 Mil. This investment constitutes 8.1% of their stock portfolio, and Catalio Capital Management, LP now holds 0.51% of the outstanding BridgeBio Pharma Inc(BBIO) stock.

The initial trade took place in 2024Q4. And since then Catalio Capital Management, LP has made 1 purchases of BBIO, at an average price of $26.39, for a total of 962,883.00 shares. Based on historical transaction data and BBIO's current price of $43.50, Catalio Capital Management, LP's estimated gain on his BBIO holdings is $16.48 Mil, reflecting a 64.86% gain to date.

Catalio Capital Management, LP BBIO ($43.50) Holding Chart

Catalio Capital Management, LP BBIO ($43.50) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1